KATHERINE SIEDOR: Open Payments
NPI 1285013458 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 33 payments from 14 companies in 2025. Trend: 2023 $1,721 · 2024 $1,088 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $104 |
| ABBVIE INC. | 5 | $95 |
| Arcutis Biotherapeutics, Inc. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| UCB, Inc. | 3 | $60 |
| Amgen Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Janssen Biotech, Inc. | 3 | $45 |
| Incyte Corporation | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $37 |
Products named: DUPIXENT, Zoryve, Rhapsido, Bimzelx, Otezla, RINVOQ, Sotyktu, TREMFYA.
Industry payments across GA — which companies pay providers there.
